13 results on '"Oueslati, Saoussen"'
Search Results
2. The occurrence of the carbapenemase gene, bla NDM-5 , on a transmissible IncX3 plasmid in multidrug-resistant Escherichia coli isolated from a farm dog.
- Author
-
Daaboul D, Kassem II, El Omari K, Dabboussi F, Oueslati S, Naas T, and Osman M
- Subjects
- Dogs, Humans, Animals, Aztreonam pharmacology, Farms, Drug Resistance, Multiple, Bacterial genetics, Plasmids genetics, Anti-Bacterial Agents pharmacology, Escherichia coli, Escherichia coli Infections veterinary, Escherichia coli Infections epidemiology, Bacterial Proteins, beta-Lactamases
- Abstract
Objectives: In-depth phenotypic and genomic analyses on a carbapenem-resistant Escherichia coli isolate, recovered from the faeces of a farm dog in Lebanon, focusing on its antimicrobial resistance (AMR) patterns and the underlying resistome., Methods: E. coli strain EC-106 was identified using MALDI-TOF-MS. Analyses using Carba NP, immunochromatographic assay NG Carba5, and other antimicrobial susceptibility testing were performed. Whole-genome sequencing (WGS) using the Illumina technology and different software available at the Center of Genomic Epidemiology wwere used to predict the resistome, sequence type (ST), plasmid types, and virulence genes., Results: Susceptibility testing revealed that E. coli EC-106 was multi-drug resistant, including against newer antimicrobials such as imipenem-relebactam (MIC = 16 µg/mL), meropenem-vaborbactam (MIC = 16 µg/mL), and ceftazidime-avibactam (MIC > 32 µg/mL), but remained susceptible to aztreonam (MIC = 0.12 µg/mL), aztreonam-avibactam (MIC = 0.06 µg/mL), and cefiderocol (MIC = 0.5 µg/mL). WGS analyses showed that E. coli EC-106 carried 13 acquired resistance genes associated with resistance to β-lactams (bla
NDM-5 and blaTEM-1B ), aminoglycosides (aac(3)-IId, aph(3')-Ia, aadA1, and aadA2), tetracyclines (tetA), amphenicols (partial catA1), macrolides (mphA), sulphonamides (sul1 and sul3), trimethoprim (dfrA12), and quaternary ammonium compounds (partial qacE). The blaNDM-5 was located on an IncX3 plasmid. The isolate was predicted to be a human pathogen (92.9%) and belonged to ST1011., Conclusion: To our knowledge, this is the first report of the detection of an IncX3 plasmid carrying the blaNDM-5 gene in animals in Lebanon, highlighting the severe AMR challenges in the country. Taken together, our current and previous findings suggest that blaNDM-5 might be spreading in different hosts and genetic backgrounds across clinical and non-clinical settings., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
3. Role of Arginine 214 in the Substrate Specificity of OXA-48.
- Author
-
Oueslati S, Retailleau P, Marchini L, Berthault C, Dortet L, Bonnin RA, Iorga BI, and Naas T
- Subjects
- Amino Acid Substitution, Anti-Bacterial Agents pharmacology, Carbapenems metabolism, Crystallography, X-Ray, Enterobacteriaceae drug effects, Imipenem pharmacology, Kinetics, Microbial Sensitivity Tests, Models, Molecular, Mutation genetics, Penicillins metabolism, Arginine genetics, Arginine metabolism, Bacterial Proteins genetics, Bacterial Proteins metabolism, Drug Resistance, Bacterial genetics, Enterobacteriaceae genetics, Substrate Specificity genetics, beta-Lactamases genetics, beta-Lactamases metabolism
- Abstract
Increasing numbers of variants of the carbapenem-hydrolyzing class D β-lactamase OXA-48 are identified in Enterobacterales worldwide. Among them, OXA-181 and OXA-232 are of particular interest, as they differ from each other by a single amino acid substitution at position 214 (R in OXA-181 and S in OXA-232) that results in reduced carbapenem-hydrolyzing activity for OXA-232. To investigate the role of amino acid position 214 (AA214), the X-ray structure of OXA-232 was determined and AA214 of OXA-48 and of OXA-232 was replaced by G, L, D, E, S, R, and K using site-directed mutagenesis. These mutants were phenotypically characterized, and three mutants of OXA-232 were purified to study their steady-state kinetic properties. The X-ray structure of OXA-232 along with molecular modeling studies showed that the interaction via a salt bridge between R214 and D159 in OXA-48 is not possible with the G214 or S214 mutation. In contrast, with K214, which is also positively charged, the interaction with D159 is maintained. With the E214 mutant, an alternative binding conformation of imipenem that is not compatible with a nucleophilic attack by S70 was evidenced. Thus, imipenem has a very poor apparent affinity for the E214 mutant because of its nonproductive binding mode. Similarly, we could explain the lack of temocillin hydrolysis by the OXA-232-S214E mutant, which is due to the unfavorable interaction between the negatively charged R1 substituent of temocillin with the E214 residue. Overall, we demonstrate that AA214 in OXA-48-like β-lactamases is critical for the carbapenemase activity., (Copyright © 2020 American Society for Microbiology.)
- Published
- 2020
- Full Text
- View/download PDF
4. Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs.
- Author
-
Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Fortineau N, and Naas T
- Subjects
- Bacteria isolation & purification, Bacterial Proteins biosynthesis, Humans, Reagent Kits, Diagnostic, Retrospective Studies, Sensitivity and Specificity, beta-Lactamases biosynthesis, Bacteria genetics, Bacterial Infections diagnosis, Bacterial Infections microbiology, Bacterial Proteins genetics, Multiplex Polymerase Chain Reaction, Real-Time Polymerase Chain Reaction, Rectum microbiology, beta-Lactamases genetics
- Abstract
A novel real-time multiplex PCR assay, BD MAX Check-Points CPO, was evaluated to detect carbapenemase-producing organisms in clinical settings on the BD MAX system. A total of 175 well-characterized isolates (including 123 carbapenemase producers) and 128 rectal swab specimens (including 83 positives) of patients considered at high risk for carriage of carbapenemase producers were included. Bacterial suspensions were used to spike true-negative rectal swabs to mimic a clinical sample. Sample (50 μL), containing either the spiked or the patient's sample, was processed. The BD MAX Check-Points CPO assay detected carbapenemases KPC, VIM/IMP, NDM, and OXA-48-like producers with a high sensitivity and specificity of 97.1% and 98.8%, respectively. Rare variants of the IMP type (IMP-11, IMP-13, and IMP-14) and one rare and distantly related OXA-48 variant (OXA-535) remained undetected. With patients' rectal swabs, sensitivity and specificity were 92.8% and 97.8%, respectively. Failure of detection was due to weak inoculum. The time to result was short: approximately. 2.5 hours for 12 samples (including extraction and PCR). The automated sample-in results-out platform is an efficient, quick, and easy-to-use tool for the detection of the main five carbapenemases. The lack of distinction between producers of VIM and IMP may be limiting in countries where these enzymes are widespread, as in Asia, but not in France, where IMP producers are extremely rare., (Copyright © 2020 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
5. Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected.
- Author
-
Volland H, Girlich D, Laguide M, Gonzalez C, Paris V, Laroche M, Oueslati S, Dortet L, Simon S, and Naas T
- Subjects
- Acinetobacter pathogenicity, Bacterial Proteins genetics, Microbial Sensitivity Tests, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa metabolism, beta-Lactamases genetics, Bacterial Proteins metabolism, Immunoassay methods, beta-Lactamases metabolism
- Abstract
Here, we evaluated the immunochromatographic assay NG-Test Carba 5v2 (NG-Biotech), with improved IMP variant detection on 31 IMP producers, representing the different branches of the IMP phylogeny, including 32 OXA-48, 19 KPC, 12 VIM, 14 NDM, and 13 multiple carbapenemase producers (CPs), 13 CPs that were not targeted, and 13 carbapenemase-negative isolates. All tested IMP variants were accurately detected without impairing detection of the other carbapenemases. Thus, NG-Test Carba 5v2 is now well adapted to countries with high IMP prevalence and to the epidemiology of CP- Pseudomonas aeruginosa , where IMPs are most frequently detected., (Copyright © 2019 American Society for Microbiology.)
- Published
- 2019
- Full Text
- View/download PDF
6. Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity.
- Author
-
Oueslati S, Iorga BI, Tlili L, Exilie C, Zavala A, Dortet L, Jousset AB, Bernabeu S, Bonnin RA, and Naas T
- Subjects
- Amino Acid Substitution, Bacterial Proteins genetics, Cloning, Molecular, Drug Combinations, Escherichia coli genetics, Genetic Variation, Kinetics, Klebsiella pneumoniae genetics, Microbial Sensitivity Tests, Molecular Docking Simulation, Mutagenesis, Site-Directed, beta-Lactamases genetics, Anti-Bacterial Agents pharmacology, Azabicyclo Compounds pharmacology, Bacterial Proteins analysis, Ceftazidime pharmacology, Klebsiella pneumoniae drug effects, beta-Lactamases analysis
- Abstract
Background: KPC-like carbapenemases have spread worldwide with more than 30 variants identified that differ by single or double amino-acid substitutions., Objectives: To describe the steady-state kinetic parameters of KPC-28, which differs from KPC-2 by a H274Y substitution and the deletion of two amino acids (Δ242-GT-243)., Methods: The blaKPC-2, blaKPC-3, blaKPC-14 and blaKPC-28 genes were cloned into a pTOPO vector for susceptibility testing or into pET41b for overexpression, purification and subsequent kinetic parameter (Km, kcat) determination. Molecular docking experiments were performed to explore the role of the amino-acid changes in the carbapenemase activity., Results: Susceptibility testing revealed that Escherichia coli producing KPC-28 displayed MICs that were lower for carbapenems and higher for ceftazidime and ceftazidime/avibactam as compared with KPC-2. The catalytic efficiencies of KPC-28 and KPC-14 for imipenem were 700-fold and 200-fold lower, respectively, than those of KPC-2, suggesting that Δ242-GT-243 in KPC-28 and KPC-14 is responsible for reduced carbapenem hydrolysis. Similarly, the H274Y substitution resulted in KPC-28 in a 50-fold increase in ceftazidime hydrolysis that was strongly reversed by clavulanate., Conclusions: We have shown that KPC-28 lacks carbapenemase activity, has increased ceftazidime hydrolytic activity and is strongly inhibited by clavulanate. KPC-28-producing E. coli isolates display an avibactam-resistant ESBL profile, which may be wrongly identified by molecular and immunochromatographic assays as the presence of a carbapenemase. Accordingly, confirmation of carbapenem hydrolysis will be mandatory with assays based solely on blaKPC gene or gene product detection., (© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
7. False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei.
- Author
-
Jousset AB, Oueslati S, Bernabeu S, Takissian J, Creton E, Vogel A, Sauvadet A, Cotellon G, Gauthier L, Bonnin RA, Dortet L, and Naas T
- Subjects
- Cephalosporinase genetics, Cephalosporinase metabolism, Enterobacter enzymology, Hydrolysis, Kinetics, Microbial Sensitivity Tests, Bacterial Proteins metabolism, Carbapenems metabolism, Carbapenems pharmacology, Enterobacter drug effects, beta-Lactamases metabolism
- Abstract
In Enterobacter cloacae complex (ECC), the overproduction of the chromosome-encoded cephalosporinase (cAmpC) associated with decreased outer membrane permeability may result in carbapenem resistance. In this study, we have characterized ACT-28, a cAmpC with weak carbapenemase activity, from a single Enterobacter kobei lineage. ECC clinical isolates were characterized by whole-genome sequencing (WGS), susceptibility testing, and MIC, and carbapenemase activity was monitored using diverse carbapenem hydrolysis methods. ACT-28 steady-state kinetic parameters were determined. Among 1,039 non-carbapenemase-producing ECC isolates with decreased susceptibility to carbapenems received in 2016-2017 at the French National Reference Center for antibiotic resistance, only 8 had a positive carbapenemase detection test (Carba NP). These eight ECC isolates were resistant to broad-spectrum cephalosporins due to AmpC derepression, showed decreased susceptibility to carbapenems, and were categorized as carbapenemase-producing Enterobacteriaceae (CPE) according to several carbapenemase detection assays. WGS identified a single clone of E. kobei ST125 expressing only its cAmpC, ACT-28. The bla
ACT-28 gene was expressed in a wild-type and in a porin-deficient Escherichia coli background and compared to the blaACT-1 gene. Detection of carbapenemase activity was positive only for E. coli expressing the blaACT-28 gene. Kinetic parameters of purified ACT-28 revealed a slightly increased imipenem hydrolysis compared to that of ACT-1. In silico porin analysis revealed the presence of a peculiar OmpC-like protein specific to E. kobei ST125 that could impair carbapenem influx into the periplasm and thus enhance carbapenem-resistance caused by ACT-28. We described a widespread lineage of E. kobei ST125 producing ACT-28, with weak carbapenemase activity that can lead to false-positive detection by several biochemical and phenotypic diagnostic tests., (Copyright © 2019 American Society for Microbiology.)- Published
- 2019
- Full Text
- View/download PDF
8. A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae.
- Author
-
Boutal H, Vogel A, Bernabeu S, Devilliers K, Creton E, Cotellon G, Plaisance M, Oueslati S, Dortet L, Jousset A, Simon S, Naas T, and Volland H
- Subjects
- Bacterial Proteins immunology, Carbapenem-Resistant Enterobacteriaceae enzymology, Cross Reactions, Sensitivity and Specificity, Time Factors, beta-Lactamases immunology, Bacterial Proteins analysis, Carbapenem-Resistant Enterobacteriaceae isolation & purification, Enterobacteriaceae Infections microbiology, Immunoassay methods, beta-Lactamases analysis
- Abstract
Objectives: The global spread of carbapenemase-producing Enterobacteriaceae represents a substantial challenge in clinical practice and rapid and reliable detection of these organisms is essential. The aim of this study was to develop and validate a lateral flow immunoassay (Carba5) for the detection of the five main carbapenemases (KPC-, NDM-, VIM- and IMP-type and OXA-48-like)., Methods: Carba5 was retrospectively and prospectively evaluated using 296 enterobacterial isolates from agar culture. An isolated colony was suspended in extraction buffer and then loaded on the manufactured Carba5., Results: All 185 isolates expressing a carbapenemase related to one of the Carba5 targets were correctly and unambiguously detected in <15 min. All other isolates gave negative results except those producing OXA-163 and OXA-405, which are considered low-activity carbapenemases. No cross-reaction was observed with non-targeted carbapenemases, ESBLs, AmpCs or oxacillinases (OXA-1, -2, -9 and -10). Overall, this assay reached 100% sensitivity and 95.3% (retrospectively) to 100% (prospectively) specificity., Conclusions: Carba5 is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for confirmation of the five main carbapenemases encountered in Enterobacteriaceae.
- Published
- 2018
- Full Text
- View/download PDF
9. Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria.
- Author
-
Oueslati S, Girlich D, Dortet L, and Naas T
- Subjects
- Gram-Negative Bacteria genetics, Gram-Negative Bacteria isolation & purification, Humans, Multiplex Polymerase Chain Reaction standards, Reagent Kits, Diagnostic, Reproducibility of Results, Sensitivity and Specificity, Vancomycin-Resistant Enterococci enzymology, Vancomycin-Resistant Enterococci genetics, Vancomycin-Resistant Enterococci isolation & purification, beta-Lactam Resistance genetics, Bacterial Proteins genetics, Gram-Negative Bacteria enzymology, Gram-Negative Bacterial Infections microbiology, Molecular Diagnostic Techniques standards, beta-Lactamases genetics
- Abstract
As carbapenemase-producing Gram-negative bacilli (CP-GNB) ( Enterobacteriaceae , Pseudomonadaceae , and Acinetobacter spp.) are becoming a major public health issue, there is an urgent need for accurate and fast diagnostic tests. The Amplidiag CarbaR+VRE assay is a multiplex nucleic acid-based in vitro diagnostic test intended for the detection of CP-GNB and vancomycin-resistant enterococci (VRE) from cultured colonies. We have evaluated its ability to detect carbapenemase genes in 100 well-characterized GNB and in 200 consecutive enterobacterial isolates with reduced susceptibility to carbapenems that were referred to the French National Reference Center for carbapenem resistance. The assay has been validated on purified DNA but also directly on colonies. The Amplidiag CarbaR+VRE assay could detect all KPC, NDM, VIM, IMP, and OXA-48-like variants tested and all acquired carbapenem-hydrolyzing oxacillinases from Acinetobacter baumannii (OXA-23, OXA-24/-40, and OXA-58) as well as the overexpressed chromosomally encoded OXA-51-like β-lactamase associated with an upstream inserted IS Aba1 However, as claimed by the manufacturer, other carbapenemases such as GES-like carbapenemases (GES-2, GES-5, and GES-14), GIM-1, AIM-1, SPM-1, DIM-1, OXA-198 in Pseudomonas aeruginosa , or OXA-143-like in A. baumannii were not detected. Amplidiag CarbaR+VRE's performance values were high (100% sensitivity and 99% specificity) as it could detect the five major carbapenemases-NDM, VIM, IMP, KPC, and OXA-48-as well as OXA-type carbapenemases from Acinetobacter spp. that are currently emerging also among Proteus mirabilis and other enterobacterial isolates. It can provide a result directly from colonies growing on Mueller-Hinton (MH) agar or on selective screening medium in less than 2 h. Further evaluations are now necessary to determine the performance values directly on rectal swabs., (Copyright © 2018 American Society for Microbiology.)
- Published
- 2018
- Full Text
- View/download PDF
10. Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity.
- Author
-
Dortet L, Oueslati S, Jeannot K, Tandé D, Naas T, and Nordmann P
- Subjects
- Adult, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Base Sequence, Carbapenems therapeutic use, Cephalosporins therapeutic use, DNA, Bacterial genetics, Female, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Plasmids genetics, Sequence Analysis, DNA, Serratia Infections microbiology, Serratia marcescens genetics, Serratia marcescens isolation & purification, beta-Lactamases chemistry, beta-Lactamases metabolism, Anti-Bacterial Agents therapeutic use, Bacterial Proteins genetics, Drug Resistance, Multiple, Bacterial genetics, Serratia Infections drug therapy, Serratia marcescens drug effects, beta-Lactamases genetics
- Abstract
The epidemiology of carbapenemases worldwide is showing that OXA-48 variants are becoming the predominant carbapenemase type in Enterobacteriaceae in many countries. However, not all OXA-48 variants possess significant activity toward carbapenems (e.g., OXA-163). Two Serratia marcescens isolates with resistance either to carbapenems or to extended-spectrum cephalosporins were successively recovered from the same patient. A genomic comparison using pulsed-field gel electrophoresis and automated Rep-PCR typing identified a 97.8% similarity between the two isolates. Both strains were resistant to penicillins and first-generation cephalosporins. The first isolate was susceptible to expanded-spectrum cephalosporins, was resistant to carbapenems, and had a significant carbapenemase activity (positive Carba NP test) related to the expression of OXA-48. The second isolate was resistant to expanded-spectrum cephalosporins, was susceptible to carbapenems, and did not express a significant imipenemase activity, (negative for the Carba NP test) despite possessing a blaOXA-48-type gene. Sequencing identified a novel OXA-48-type β-lactamase, OXA-405, with a four-amino-acid deletion compared to OXA-48. The blaOXA-405 gene was located on a ca. 46-kb plasmid identical to the prototype IncL/M blaOXA-48-carrying plasmid except for a ca. 16.4-kb deletion in the tra operon, leading to the suppression of self-conjugation properties. Biochemical analysis showed that OXA-405 has clavulanic acid-inhibited activity toward expanded-spectrum activity without significant imipenemase activity. This is the first identification of a successive switch of catalytic activity in OXA-48-like β-lactamases, suggesting their plasticity. Therefore, this report suggests that the first-line screening of carbapenemase producers in Enterobacteriaceae may be based on the biochemical detection of carbapenemase activity in clinical settings., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
11. Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
- Author
-
Oueslati, Saoussen, Volland, Hervé, Cattoir, Vincent, Bernabeu, Sandrine, Girlich, Delphine, Dulac, Ducan, Plaisance, Marc, Laroche, Maxime, Dortet, Laurent, Simon, Stéphanie, and Naas, Thierry
- Subjects
- *
IMMUNOASSAY , *MEDICAL microbiology , *ENTEROCOCCUS , *AGAR plates , *BACTERIAL growth , *DETECTION limit , *BACTERIAL proteins , *VANCOMYCIN resistance , *RESEARCH , *RESEARCH methodology , *VANCOMYCIN , *MEDICAL cooperation , *EVALUATION research , *GRAM-positive bacterial infections , *COMPARATIVE studies , *ENZYMES - Abstract
Background: VRE are nosocomial pathogens with an increasing incidence in recent decades. Rapid detection is crucial to reduce their spread and prevent infections and outbreaks.Objectives: To evaluate a lateral flow immunoassay (LFIA) (called NG-Test VanA) for the rapid and reliable detection of VanA-producing VRE (VanA-VRE) from colonies and broth.Methods: NG-Test VanA was validated on 135 well-characterized enterococcal isolates grown on Mueller-Hinton (MH) agar (including 40 VanA-VRE). Different agar plates and culture broths widely used in routine laboratories for culture of enterococci were tested.Results: All 40 VanA-VRE clinical isolates were correctly detected in less than 15 min irrespective of the species expressing the VanA ligase and the medium used for bacterial growth. No cross-reaction was observed with any other clinically relevant ligases (VanB, C1, C2, D, E, G, L, M and N). Overall, the sensitivity and specificity of the assay were 100% for VanA-VRE grown on MH agar plates. NG-Test VanA accurately detects VanA-VRE irrespective of the culture medium (agar and broth). Band intensity was increased when using bacteria grown on vancomycin-containing culture media or on MH close to the vancomycin disc as a consequence of VanA induction. The limit of detection of the assay was 6.3 × 106 cfu per test with bacteria grown on MH plates and 4.9 × 105 cfu per test with bacteria grown on ChromID® VRE plates.Conclusions: NG-Test VanA is efficient, rapid and easy to implement in the routine workflow of a clinical microbiology laboratory for the confirmation of VanA-VRE. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
12. Different phenotypic expression of KPC β-lactamase variants and challenges in their detection.
- Author
-
Oueslati, Saoussen, Tlili, Linda, Exilie, Cynthia, Bernabeu, Sandrine, Iorga, Bogdan, Bonnin, Rémy A, Dortet, Laurent, and Naas, Thierry
- Subjects
- *
BACTERIAL proteins , *KLEBSIELLA , *HYDROLASES , *ENZYME inhibitors , *ANTIBIOTICS , *MICROBIAL sensitivity tests , *PHARMACODYNAMICS - Abstract
Different phenotypic expression of KPC -lactamase variants and challenges in their detection. [Extracted from the article]
- Published
- 2020
- Full Text
- View/download PDF
13. Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response.
- Author
-
Muntean, Mădălina Maria, Muntean, Andrei-Alexandru, Guerin, François, Cattoir, Vincent, Creton, Elodie, Cotellon, Garance, Oueslati, Saoussen, Popa, Mircea Ioan, Girlich, Delphine, Iorga, Bogdan I., Bonnin, Rémy A., and Naas, Thierry
- Subjects
ANTIBIOTICS ,BACTERIAL proteins ,HYDROLASES ,CARBAPENEMS ,MICROBIAL sensitivity tests ,PHARMACODYNAMICS - Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.